surtavi: savr or tavi for a patient at high risk for stroke? europcr 2017 hot line
Published 7 years ago • 348 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
4:31
dr. reardon on the surtavi trial - tavr vs savr for intermediate risk patients
-
6:30
savr vs. tavr: how to decide?
-
52:20
savr vs. tavr patient webinar: what should patients know?
-
2:05
surtavi: tavi versus surgery in intermediate risk as patients - acc.17
-
7:30
europcr 21: tavr for bav stenosis in low surgical risk patients
-
1:09:12
tavi, savr, pci and low risk patients
-
12:35
thirty-day outcomes of a new self-expanding transcatheter heart valve - europcr 2017
-
56:23
challenges and opportunities in high-risk patients undergoing tavi - europcr 2021
-
15:24
aortic stenosis: tavr or savr
-
0:32
tavi procedure: a safe and effective treatment option for elderly patients with aortic stenosis
-
1:27:56
tavi in bicuspid aortic valve patients. sapien 3 platform a safe and efficient option - europcr 2021
-
15:30
surtavi: what do you need to know considering the new esc guidelines? - pcr london valves 2021
-
1:01:27
how do i ensure long valve durability for my tavi patients? - webinar
-
56:43
tavr vs savr in treatment of aortic stenosis
-
10:12
surtavi expands the treatment options available for more patients
-
24:34
transcatheter valve replacement (tavr) and savr-update on outcome
-
28:16
episode 19 | transcatheter aortic valve replacement (tavr) vs surgical aortic valve replacement
-
32:14
the treatment of aortic valve disease in 2020, a surgeon’s perspective (michael j. reardon, md)
-
6:19
stroke risk & transcatheter aortic valve replacement (tavr) with dr. isaac george